Cargando…
Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA
Background: It has been shown repeatedly that mast cells can promote or prevent cancer development and growth. If development and/or progression of a solid cancer is substantially influenced by mast cell activity, the frequencies of occurrence of solid cancers in patients with primary mast cells di...
Autores principales: | Molderings, Gerhard J., Zienkiewicz, Thomas, Homann, Jürgen, Menzen, Markus, Afrin, Lawrence B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710302/ https://www.ncbi.nlm.nih.gov/pubmed/29225779 http://dx.doi.org/10.12688/f1000research.12730.1 |
Ejemplares similares
-
Pharmacological treatment options for mast cell activation disease
por: Molderings, Gerhard J., et al.
Publicado: (2016) -
Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options
por: Molderings, Gerhard J, et al.
Publicado: (2011) -
A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms
por: Molderings, Gerhard J., et al.
Publicado: (2023) -
Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
por: Afrin, Lawrence B., et al.
Publicado: (2020) -
Mast cell activation symptoms are prevalent in Long-COVID
por: Weinstock, Leonard B., et al.
Publicado: (2021)